Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Histologically-confirmed Malignancies × alovudine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4 Brain Neoplasms 3 Oligodendroglioma 1 Neoplasms 1 Lung Neoplasms 1 Histologically-confirmed Malignancies 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Ependymoma 1 Central Nervous System Neoplasms 1 Breast Neoplasms, Male 1 Astrocytoma 1 Adult Women With a New Diagnosis of Invasive Breast Cancer (Have Not Undergone Treatment) 1

Interventions

alovudine 1 Positron Emission Tomography Computed Tomography 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02139150 2019-09-17

Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy

Memorial Sloan Kettering Cancer Center

Phase NA Withdrawn

Histologically-confirmed Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡